MEDRYLAMINE,
524-99-2,
2-[(4-methoxyphenyl)-phenyl-methoxy]-N,N-dimethyl-ethanamine,
Histaphene,
Medrilamina,
Medrylaminum,
Medrylamine [INN:DCF],
Medrylaminum [INN-Latin],
Medrilamina [INN-Spanish],
Medrylamin,
EINECS 208-368-6,
AC1L1VOZ,
SCHEMBL142910,
CHEMBL2104714,
CHEBI:135181,
MFCD00865690,
AKOS030227994,
KS-000000H5,
{2-[(4-Methoxyphenyl)phenylmethoxy]ethyl}dimethylamine,
2-(p-Methoxy-alpha-phenylbenzyloxy)-N,N-dimethylethylamine,
2-[(4-methoxyphenyl)-phenylmethoxy]-N,N-dimethylethanamine,
histaphen,
Postafen,
Antihistamine compound,
Medrylamine [DCF:INN],
UNII-5R003655CR,
C18H23NO2,
CID10669,
C18-H23-N-O2,
5R003655CR,
2-((4-methoxyphenyl)(phenyl)methoxy)-N,N-dimethylethanamine,
Ethanamine, 2-((4-methoxyphenyl)phenylmethoxy)-N,N-dimethyl-,